M4E(R2)
Common Technical Document on Efficacy
Current edition
Step 4, 15 June 2016
Current edition
Step 4, 15 June 2016
About this standard
Describes the structure and format of the clinical data in a dossier, including the clinical summaries and detailed study reports, and the format of benefit-risk information.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
- United StatesImplemented
- Edition accepted
- -
- National code
- Vol. 82 No. 141 p. 34538-3539
Effective July 25, 2017
- JapanImplemented
- Edition accepted
- -
- National code
- PSEHB/PELD Notification No. 0202-1
Effective February 1, 2017
- ChinaImplemented
- Edition accepted
- -
- National code
- CFDA, China Announcement No. 10 (2018)
Effective February 1, 2018
- BrazilImplemented
- Edition accepted
- -
- National code
- -
- GUIA PARA A ORGANIZAÇÃO DO DOCUMENTO TÉCNICO COMUM (CTD) PARA O REGISTRO E PÓS-REGISTRO DE MEDICAMENTOS
Effective August 14, 2019
- South KoreaImplemented
- Edition accepted
- -
- National code
- -
- Regulation on Pharmaceuticals Approval, Notification and Review [MFDS, Republic of Korea Notification ]
Effective June 30, 2016
- SwitzerlandImplemented
- Edition accepted
- -
- National code
- Swissmedic, Switzerland press release
Effective June 1, 2016
- MexicoImplemented
- Edition accepted
- -
- National code
- -
Required: applications for registration of a medicine and for changes to a registration are filed in CTD format under the ICH guidelines, with a Module 1 specific to Mexico.
- SingaporeImplemented
- Edition accepted
- -
- National code
- Guidance on Therapeutic Products Registration in Singapore
Effective December 1, 2016
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Mexico
- Dossier format: CTD under ICH M4 with a Mexican Module 1, language and electronic filingDossier format · Not stated
Related standards: FDA eCTD submission guidance, MDR 2017 Fourth Schedule, Appendix II and III, JP notification on electronic study data (2024), M4(R4), M4Q(R1), M4Q(R2), M4S(R2), ACTD, CDSCO Guidance for Industry (Biologicals), COFEPRIS CTD guide v3.0, DS-G-003, DS-REQ-002. See all standards.